Table 2.
Number (%) of subjects receiving staging and treatment by facility classification
| Overall Population | NCI Designation | Resident Program | Medical School Affiliation | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Yes | No | P* | Yes | No | p* | Major | Limited | None | p* | ||
| N | 2,300 | 219 | 2,081 | 1,229 | 1,070 | 613 | 571 | 1,115 | |||
| Clinical Staging | |||||||||||
| TRUS or Pelvic MRI | 758 (33.0) | 136 (62.1) | 622 (29.9) | <.0001 | 482 (39.2) | 276 (25.8) | <.0001 | 285 (46.5) | 175 (30.6) | 298 (26.7) | <.0001 |
| Pelvic CT | 1,942 (84.4) | 194 (88.6) | 1,748 (84.0) | .07 | 1,056 (85.9) | 885 (82.7) | .03 | 547 (89.2) | 482 (84.4) | 912 (81.8) | .0002 |
| PET | 432 (18.8) | 58 (26.5) | 374 (18.0) | .0022 | 243 (19.8) | 188 (17.6) | .18 | 129 (21.0) | 109 (19.1) | 193 (17.3) | .16 |
| Abdominal CT or MRI | 1,973 (85.8) | 199 (90.9) | 1,774 (85.2) | .02 | 1,075 (87.5) | 897 (83.8) | .01 | 556 (90.7) | 489 (85.6) | 927 (83.1) | <.0001 |
| Chest CT or X-ray | 1,707 (74.2) | 168 (76.7) | 1,539 (74.0) | .37 | 910 (74.0) | 796 (74.4) | .85 | 461 (75.2) | 415 (72.7) | 830 (74.4) | .59 |
| CEA Test | 1,306 (56.8) | 157 (71.7) | 1,149 (55.2) | <.0001 | 734 (59.7) | 571 (53.4) | .0021 | 370 (60.4) | 330 (57.8) | 605 (54.3) | .04 |
| Chemotherapy | |||||||||||
| Received neoadjuvant chemotherapy | 1,010 (43.9) | 140 (63.9) | 870 (41.8) | <.0001 | 586 (47.7) | 424 (39.6) | 0.0001 | 312 (50.9) | 247 (43.3) | 451 (40.4) | 0.0001 |
| Received any chemotherapy | 1,645 (71.5) | 183 (83.6) | 1,462 (70.3) | <.0001 | 892 (72.6) | 752 (70.3) | 0.22 | 453 (73.9) | 404 (70.8) | 787 (70.6) | .31 |
| % neoadjuvant among those who received any chemotherapy | 61.4 | 76.5 | 59.5 | <.0001 | 65.7 | 56.4 | 0.0001 | 68.9 | 61.1 | 57.3 | 0.0003 |
| Radiation Therapy | |||||||||||
| Received neoadjuvant radiation | 1,119 (48.7) | 155 (70.8) | 964 (46.3) | <.0001 | 655 (53.3) | 463 (43.3) | <.0001 | 354 (57.7) | 274 (48.0) | 490 (43.9) | <.0001 |
| Received any radiation | 1,616 (70.3) | 180 (82.2) | 1,436 (69.0) | <.0001 | 880 (71.6) | 735 (68.7) | .13 | 457 (74.6) | 396 (69.4) | 762 (68.3) | .02 |
| % neoadjuvant among those who received any radiation | 69.2 | 86.1 | 67.1 | <.0001 | 74.4 | 63.0 | <.0001 | 77.5 | 69.2 | 64.3 | <.0001 |
| Sphincter Preserving Surgery | 1,562 (67.9) | 150 (68.5) | 1,412 (67.9) | .85 | 848 (69.0) | 714 (66.7) | .24 | 429 (70.0) | 381 (66.7) | 752 (67.4) | .43 |
*
P values calculated using a two-sided Pearson Chi-Square test.